Outline of Survey on Long-Term Use of ORENCIA Intravenous Infusion 250mg
Phase of Trial: Phase IV
Latest Information Update: 19 Jan 2017
At a glance
- Drugs Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Bristol-Myers Squibb
- 13 Jan 2017 Status changed from active, no longer recruiting to completed.
- 05 Apr 2016 Planned End Date changed from 1 Mar 2016 to 1 Dec 2016 as reported by ClinicalTrials.gov record.
- 14 Nov 2015 New trial record